Pfizer Escapes FCA Suit Over Anti-Fungal Drug Promotions

Law360, Los Angeles (November 25, 2013, 8:38 PM EST) -- A Massachusetts federal judge on Friday dismissed an ex-Pfizer Inc. manager's False Claims Act qui tam suit accusing the drug giant of a long-running and illegal campaign to promote off-label use of anti-fungal drugs, finding the claims were too vague.

U.S. District Judge Nathaniel M. Gorton decided the claims were insufficient because they didn't contain enough details accusing Pfizer of submitting a false claim to the federal government over Vfend and Eraxis.

Paul Worsfold, a former district manager at Pfizer, said his ex-employer recklessly and unnecessarily...
To view the full article, register now.




Case Information

Case Title

United States of America et al v. Pfizer Inc

Case Number




Nature of Suit

Other Statutory Actions


Nathaniel M. Gorton

Date Filed

September 11, 2009

Law Firms


Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.